(Q47870284)

6 February 2018

title

Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

1 reference

Pessi A

1

1 reference

6 February 2018

Valmori D

2

1 reference

6 February 2018

Migliorini P

3

1 reference

6 February 2018

Tougne C

4

1 reference

6 February 2018

Bianchi E

5

1 reference

6 February 2018

Lambert PH

6

1 reference

6 February 2018

Corradin G

7

1 reference

6 February 2018

Del Giudice G

8

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 September 1991

1 reference

6 February 2018

European Journal of Immunology

published in

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

2273-2276

1 reference

6 February 2018

Rationale for the development of an engineered sporozoite malaria vaccine

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Variation among circumsporozoite protein genes from rodent malarias

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

1H-NMR studies of synthetic polypeptide models of Plasmodium falciparum circumsporozoite protein tandemly repeated sequence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Plasmodium berghei subunit vaccine: repeat synthetic peptide of circumsporozoite protein comprising T- and B-cell epitopes fails to confer immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210941

7 January 2021

Identifiers

DOI

10.1002/EJI.1830210941

1 reference

6 February 2018

1 reference

6 February 2018